课题基金 / 基金详情

PFI-BIC: Raman Spectroscopic Platform for Analysis of Volatile Organic Compound Biomarkers

PFI-BIC: Raman Spectroscopic Platform for Analysis of Volatile Organic Compound Biomarkers
PFI-BIC:用于分析挥发性有机化合物生物标志物的拉曼光谱平台
批准号:
1237916
负责人:
Angelika Niemz
金额:
$59.99万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2015-02-28

项目摘要

项目成果

Angelika Niemz的其他基金

相似基金

相关文献

中文摘要
翻译
凯克研究生院(KGI)的创新伙伴关系项目旨在开发一种紧凑、具有成本效益和用户友好的平台技术的关键技术创新,该平台技术可以在护理点或使用点进行传染病诊断或工业过程监测。该平台将使用拉曼光谱分析气相或水溶液中的有机化合物。挥发性有机化合物检测的一个关键技术挑战,该项目将解决,涉及识别和区分复杂混合物中低浓度的挥发性有机化合物特征。在现场或医疗点使用的商业上可行的平台也必须高度坚固、易于使用和具有成本效益。这个项目采用了一种与目前市场上的系统完全不同的方法。该平台包括一个一次性的VOC样品收集/预浓缩装置,它以更低的成本优于更复杂的现有设备。为了实现灵敏的VOC检测,该平台使用了一种创新的拉曼探针,它比传统的拉曼探针更敏感,但避免了表面增强拉曼光谱在拉曼传感器表面富集和检测VOC时遇到的再现性问题,这也以独特的方式增加了选择性。该团队将改进该传感器的初步变体,并将进行旨在了解关键系统参数的初步实验,同时开发灵敏度更高的第二代传感器探头,该探头体积小,坚固耐用,能够与便携式拉曼光谱仪接口。该探针将进一步适用于测量液相中的化合物,特别是在复杂的水溶液中,如细胞培养基。更广泛的影响:这项研究的更广泛的影响包括呼吸机相关肺炎、伤口感染和活动性肺结核的快速、近病人和非侵入性诊断,这可以使美国和全球的患者受益。生物反应器过程监测可确保生物药品的可靠供应。能够解决这些应用的新型平台技术的开发和商业化对直接参与这项工作的小型商业伙伴以及医疗设备和生物技术行业的潜在未来商业伙伴具有经济效益,从而增强美国的竞争力。项目启动时的合作伙伴是主要的学术机构:凯克研究生院(加州克莱蒙特)和学术合作伙伴,波莫纳学院化学系(加州克莱蒙特)。该项目涉及三家小型企业作为核心知识增强合作伙伴:Tanner Research, Inc.(蒙罗维亚,CA), Claremont BioSolutions (Upland, CA)和Lambda Solutions Inc. (Waltham, MA)。在特定目标应用领域活跃的其他合作伙伴也将参与其中,包括KCI (San Antonio, Texas)等大公司,利用KGI与生物技术和医疗设备行业的强大联系。
英文摘要
This Partnerships for Innovation project from the Keck Graduate Institute(KGI) seeks to develop the key technical innovations for a compact, cost-effective, and user-friendly platform technology that can enable infectious disease diagnosis or industrial process monitoring at the point-of-care or point-of-use. The platform will use Raman spectroscopy to analyze organic compounds in the gas phase or in aqueous solution. A key technical challenge for VOC detection, which this project will address, relates to identifying and distinguishing VOC signatures at low concentrations in complex mixtures. Commercially viable platforms for use in the field or at the point-of-care also must be highly robust, easy-to-use, and cost-effective. This project employs a fundamentally different approach than currently marketed systems. The platform involves a disposable, VOC sample collection/pre-concentration device, which out-performs more elaborate existing devices at lower cost. To enable sensitive VOC detection, the platform uses an innovative Raman probe, which is more sensitive than conventional Raman probes, but circumvents the reproducibility problems encountered with Surface Enhanced Raman Spectroscopy VOCs enriched and detected at the Raman sensor surface in a unique manner which also increases selectivity. The team will refine a preliminary variant of this sensor and will perform initial experiments aimed at understanding key system parameters, while simultaneously developing a second generation sensor probe with increased sensitivity, that is small, robust, and capable of being interfaced with a portable Raman spectrometer.The probe will further be adapted for measuring compounds in the liquid phase, specifically in complex aqueous solutions such as cell culture media. Broader Impacts: The broader impacts of this research include rapid, near patient, and non-invasive diagnosis of ventilator associated pneumonia, wound infections, and active tuberculosis that can benefit patients in the U.S. and globally. Bioreactor process monitoring ensures a reliable supply of biopharmaceuticals. Enabling the development and commercialization of a novel platform technology that can address these applications has economic benefits for the small business partners directly involved in this effort, and for potential future business partners in the medical device and biotech industry, thereby enhancing U.S. competitiveness. Partners at the inception of the project are the lead academic institution: Keck Graduate Institute (Claremont, CA), and an academic partner, the chemistry department at Pomona College (Claremont, CA). The project involves three small businesses as core Knowledge-Enhancement Partners: Tanner Research, Inc. (Monrovia, CA), Claremont BioSolutions (Upland, CA), and Lambda Solutions Inc (Waltham, MA). Other partners active in the specific targeted applications areas will be involved in the effort, including large companies such as KCI (San Antonio, Texas), leveraging KGI's strong connections with the biotech and medical device industry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REU site: Summer Undergraduate Research in Biotechnology and Bioengineering
  • 批准号:
    0552962
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $0.0万
  • 财政年份:
    2006
  • 负责人:
    Angelika Niemz
  • 依托单位:
Electronic DNA detection on semiconductors involving DNA nanospheres
  • 批准号:
    0501629
  • 项目类别:
    Standard Grant
  • 资助金额:
    $0.0万
  • 财政年份:
    2005
  • 负责人:
    Angelika Niemz
  • 依托单位:
Undergraduate Research in Biotechnology and Bioengineering
  • 批准号:
    0243910
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $21.77万
  • 财政年份:
    2003
  • 负责人:
    Angelika Niemz
  • 依托单位:
国内基金
海外基金
金属-介电杂化BIC的多模式耦合与调控研究
  • 批准号:
    2026JJ90077
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    蒋藩
  • 依托单位:
高效率、 多功能太赫兹非局域BIC超表面波前调制器
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    凡俊兴
  • 依托单位:
BIC/FTC/TAF治疗HIV感染者身体成份与代谢指标的变化趋势及影响因素的研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    闫俊
  • 依托单位:
高性能单向面发射拓扑BIC光子晶体激光器的研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    曾永全
  • 依托单位: